Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
platelet aggregation28 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00009 | 35256195 | Thromb Res | Impaired fibrinolysis without hypercoagulability characterises patients with non-alcoholic fatty liver disease. | 2022 | Details |
| A01756 | 34628383 | Georgian Med News | THE INFLUENCE OF HYPERCHOLESTEROLEMIA AND CONCOMITANT STATIN THERAPY ON THE STATE OF PLATELET-PLASMA HEMOSTASIS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND NON-ALCOHOLIC FATTY LIVER DISEASE. | 2021 | Details |
| A03935 | 33813276 | Biochem Biophys Res Commun | Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD. | 2021 | Details |
| A05662 | 33169375 | Br J Pharmacol | Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases. | 2020 | Details |
| A11027 | 31077838 | Clin Gastroenterol Hepatol | Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11327 | 30936549 | Nat Med | Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. | 2019 | Details |
| A14947 | 29161233 | J Basic Clin Physiol Pharmacol | Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease. | 2018 | Details |
| A16899 | 28104990 | World J Gastroenterol | Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial. | 2017 | Details |
| A17164 | 27938560 | Zhonghua Gan Zang Bing Za Zhi | [Effect of targeted inhibition of hypoxia-inducible factor-1α by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole on the progression of non-alcoholic fatty liver disease in rats]. | 2016 | Details |
| A17616 | 27713972 | Food Funct | Vascular- and hepato-protective effects of passion fruit seed extract containing piceatannol in chronic high-fat diet-fed rats. | 2016 | Details |
| A19920 | 26265520 | Arch Iran Med | PolyPill for Prevention of Cardiovascular Disease in an Urban Iranian Population with Special Focus on Nonalcoholic Steatohepatitis: A Pragmatic Randomized Controlled Trial within a Cohort (PolyIran - Liver) - Study Protocol. | 2015 | Details |
| A23709 | 23548197 | J Hepatol | Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. | 2013 | Details |
| A24832 | 22450341 | Hormones (Athens) | Adiponectin: regulation of its production and its role in human diseases. | 2012 | Details |
| A24870 | 22418887 | Semin Liver Dis | Hypercoagulation and thrombophilia in nonalcoholic fatty liver disease: mechanisms, human evidence, therapeutic implications, and preventive implications. | 2012 | Details |
| A25190 | 22105182 | J Clin Gastroenterol | Coronary artery stents and antiplatelet therapy in patients with cirrhosis. | 2012 | Details |
| A25520 | 21748765 | Hepatology | Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. | 2011 | Details |
| A27348 | 18596193 | Gut | Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. | 2008 | Details |
| A27746 | 17539815 | Hepatol Res | A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. | 2007 | Details |
| A28068 | 16531961 | Ann Hepatol | Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis. | 2006 | Details |
| A34863 | 22403205 | J Am Board Fam Med | Navigating change: how outreach facilitators can help clinicians improve patient outcomes. | 2012 | Details |
| A36299 | 18503139 | Clin Hemorheol Microcirc | Red cell aggregation as a factor influencing margination and adhesion of leukocytes and platelets. | 2008 | Details |
| A42849 | 33297754 | Arterioscler Thromb Vasc Biol | The Dynamic Platelet Transcriptome in Obesity and Weight Loss. | 2020 | Details |
| A43427 | 31740806 | Nat Rev Gastroenterol Hepatol | What's new in NAFLD pathogenesis, biomarkers and treatment? | 2020 | Details |
| A45925 | 22045667 | Hepatology | Pentoxifylline for steatohepatitis: magic bullet or smoking gun? | 2011 | Details |
| A48189 | 20162727 | Hepatology | CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis. | 2010 | Details |
| A50147 | 35503185 | Virchows Arch | Neutrophil extracellular traps enriched with IL-1β and IL-17A participate in the hepatic inflammatory process of patients with non-alcoholic steatohepatitis. | 2022 | Details |
| A50639 | 35318571 | Indian J Gastroenterol | Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2022 | Details |
| A52631 | 24486395 | Eur J Pharmacol | Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat. | 2014 | Details |